European Organization for Research and Treatment of Cancer (EORTC) Laboratory Research Division workshop on the role of in vivo pre-clinical models in the development of contemporary cancer therapeutics, Verona, Italy, 3 February 2001
- 30 November 2001
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (16) , 1976-1980
- https://doi.org/10.1016/s0959-8049(01)00224-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trialsBritish Journal of Cancer, 2001
- Colorectal cancer chemopreventionEuropean Journal Of Cancer, 2001
- Ongoing trials with matrix metalloproteinase inhibitorsExpert Opinion on Investigational Drugs, 2000
- Development and characterization of a tamoxifen-resistant breast carcinoma xenograftBritish Journal of Cancer, 2000
- Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive AgentsJournal of Nutrition, 2000
- DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90JNCI Journal of the National Cancer Institute, 1999
- Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USAAnnals of Oncology, 1999
- Cancer Chemoprevention: Progress and PromiseJNCI Journal of the National Cancer Institute, 1998
- Anti-angiogenic therapies in cancer clinical trialsExpert Opinion on Investigational Drugs, 1998